Eric Devroe

Insider Reports History

Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, MA
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Devroe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. Chief Operating Officer Common Stock 65.3K $146K $2.24 Nov 14, 2025 Direct
Acrivon Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 141K Mar 1, 2025 Direct

Insider Reports Filed by Eric Devroe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Nov 14, 2025 1 -$1.37K 4 Nov 18, 2025 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Aug 14, 2025 1 -$852 4 Aug 18, 2025 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. May 14, 2025 1 -$699 4 May 16, 2025 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Mar 1, 2025 1 $0 4 Mar 4, 2025 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2025 1 -$3.92K 4 Feb 19, 2025 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2024 1 -$4.85K 4 Nov 18, 2024 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Aug 14, 2024 1 -$4.3K 4 Aug 16, 2024 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. May 17, 2024 2 $10.4K 4 May 21, 2024 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. May 14, 2024 1 -$5.12K 4 May 16, 2024 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Mar 1, 2024 1 $0 4 Nov 27, 2024 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2024 1 -$2.46K 4 Feb 16, 2024 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2023 1 -$12.4K 4 Nov 16, 2023 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Jun 5, 2023 2 $9.59K 4 Jun 6, 2023 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 2 $0 4 Nov 16, 2022 Chief Operating Officer
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Chief Operating Officer